Tech Company Financing Transactions
GT Medical Technologies Funding Round
MedTech Venture Partners and BlueStone Venture Partners participated in a $10 million Series A funding round for GT Medical Technologies. The round was announced on 2/1/2019.
Transaction Overview
Company Name
Announced On
2/1/2019
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
MedTech Venture Partners (Lead Investor) (Radu Cautis)
Proceeds Purpose
Funds from the round will support the commercialization of GammaTile Therapy, an FDA-cleared, surgically targeted radiation therapy (STaRT) for patients with recurrent intracranial neoplasms (brain tumors).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1809 S Holbrook Ln.
Tempe, AZ 85281
USA
Tempe, AZ 85281
USA
Phone
Website
Email Address
Overview
Our purpose is to improve the lives of patients with brain tumors. We are focused on developing safe, effective, and cost-efficient treatments for tumors that cannot be entirely removed by surgery alone. Our first innovation GammaTile Therapy, is a surgically targeted radiation therapy for recurrent intracranial neoplasms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Likens
Chief Technical Officer
David Brachman
VP - Bus. Development
Brian Martin
VP - Operations
Hernan Lopez
VP - Regulatory Affairs
Lisa Misell
VP - Sales
Craig Bushnell
Browse more venture capital transactions:
Prev: 2/1/2019: Workit Health venture capital transaction
Next: 2/1/2019: HitRecord venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs